Life Sciences: Asset Information Management

Manage documents and drawings throughout the asset lifecycle

Life Sciences companies rank amongst the most highly regulated of any industry sectors and early adopters of electronic document management (EDM) systems.

Compliance with 21 CFR Part 11 regulations apply as rigorously to the manufacturing operations as to drug development and trial processes to ensure supporting systems and documentation are validated.

The demand to bring new and innovative drugs to market requires engineering departments to build, re-configure and refurbish plants ever faster exerting time pressure on the business to validate supporting documentation before live operations can begin.

Life Sciences is one of McLaren Software's fastest growing sectors. Enterprise Engineer customers include those in manufacturing bio-therapeutic, biopharmaceutical, biomedicines and pharmaceuticals companies managing plants, facilities and engineering projects in North America and Europe.

McLaren's Enterprise Engineer solutions for the Life Sciences industry are deployed to companies across the USA and Europe.

McLaren's representative Life Sciences customers include:

  • Bayer
  • Bristol Myers Squibb
  • Centocor Johnson & Johnson
  • Eli Lilly
  • GrĂ¼nenthal
See Also...

REDUCED VALIDATION TIME

A leading Pharmaceutical Plant specializing in the production of blood plasma products have reduced validation time of changes to plant documents from several months to a few weeks using Enterprise Engineer.

The plant is now more agile and able to adapt quickly to regulatory or production demands

85% CONFIDENCE GROWTH

A McLaren biotech customer reported an 85% growth in confidence of the project documentation used in plants in the USA and Europe.

Significant savings in document distribution and printing costs, non compliance, regulatory submission and employee costs associated with manual processes have been attributed to the adoption of the system